Novo Nordisk raises 2026 outlook as Wegovy captures 65% of new US prescriptions, while Pandora faces tariff and silver price pressures.
Silver firms to $73.03 as Binance aligns precious metals perpetuals with crypto-style liquidation, ahead of key US jobs data.